MENU
+Compare
DXCM
Stock ticker: NASDAQ
AS OF
Oct 3 closing price
Price
$67.05
Change
+$0.61 (+0.92%)
Capitalization
26.29B

DXCM DexCom Forecast, Technical & Fundamental Analysis

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients... Show more

DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DXCM with price predictions
Oct 03, 2025

DXCM in +1.47% Uptrend, rising for three consecutive days on October 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where DXCM advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DXCM's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where DXCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

DXCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DXCM as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DXCM turned negative on September 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for DXCM moved below the 200-day moving average on September 22, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DXCM entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DXCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.215) is normal, around the industry mean (61.354). P/E Ratio (46.789) is within average values for comparable stocks, (37.462). Projected Growth (PEG Ratio) (0.854) is also within normal values, averaging (1.691). DXCM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (6.361) is also within normal values, averaging (81.049).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DXCM is expected to report earnings to rise 18.60% to 56 cents per share on October 30

DexCom DXCM Stock Earnings Reports
Q3'25
Est.
$0.57
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.02
The last earnings report on July 30 showed earnings per share of 47 cents, beating the estimate of 44 cents. With 4.44M shares outstanding, the current market capitalization sits at 26.29B.
A.I. Advisor
published General Information

General Information

a maker of medical devices and glucose monitoring systems

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6340 Sequence Drive
Phone
+1 858 200-0200
Employees
9600
Web
https://www.dexcom.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OBNB29.006.75
+30.34%
Osprey BNB Chain Trust
SPVU55.040.49
+0.90%
Invesco S&P 500® Enhanced Value ETF
RULE23.070.08
+0.35%
Adaptive Core ETF
DJUL46.790.02
+0.05%
FT Vest US Equity Deep Bffr ETF Jul
USCL78.48N/A
N/A
iShares Climate Conscious &TrnMSCIUSAETF

DXCM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+0.92%
ISRG - DXCM
46%
Loosely correlated
+2.11%
GKOS - DXCM
44%
Loosely correlated
+3.46%
ALGN - DXCM
44%
Loosely correlated
+2.70%
BSX - DXCM
41%
Loosely correlated
+1.14%
SYK - DXCM
41%
Loosely correlated
+1.12%
More

Groups containing DXCM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
+0.92%
Medical/Nursing Services
industry (224 stocks)
50%
Loosely correlated
+1.62%
Health Services
industry (434 stocks)
34%
Loosely correlated
+1.31%